Skip to content

Evaluation of Three-Dimensional Printed Orthodontic Molar Distalizer

Evaluation of Three-Dimensional Printed Orthodontic Molar Distalizer (Randomized Clinical Trial)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07191158
Acronym
RCT
Enrollment
28
Registered
2025-09-24
Start date
2025-02-01
Completion date
2027-04-01
Last updated
2025-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Distalization by Miniscrews, Tooth Movement Techniques

Keywords

Distalization, tooth movement, 3D printing

Brief summary

A randomized clinical trial to evaluate a newly designed 3D printed miniscrew-supported molar distalization device in comparison to the conventional miniscrew-supported distal jet appliance in correction of Class II malocclusion and upper arch crowding.

Detailed description

It is a multicenter randomized clinical trial with two parallel arms. The patients will be randomly divided into two groups, group one: conventional miniscrew-supported distal jet appliance will be used while for group two, new 3D printed miniscrew-supported molar distalizers is going to be utilized. Lateral cephalometric x-ray and digital models of upper arch will be taken before starting the treatment (T0) and at the end of molar distalization (T1). The effectiveness of the two appliances will be assessed and measured comparing patient's records before and after treatment.

Interventions

DEVICEGroup 1 conventional

Conventional miniscrew-supported distal jet appliance

DEVICEGroup 2 3D printed

New 3D printed miniscrew-supported molar distalizers

Sponsors

University of Baghdad
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The study will be a single blinded because both the patients and the investigator will be aware of the allocation during treatment, but the cephalograms and digital models will be scored and coded by an independent person, i.e. pre-and post-treatment cephalograms and digital models will be analyzed after replacing the patients' names with codes, and the examiner conducting the measurement analysis will be unaware of the group to which the patient has been allocated.

Eligibility

Sex/Gender
ALL
Age
16 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

1. Class II molar relationships bilaterally, with fully erupted 2nd molar. 2. No or minor crowding on the mandible to \[reserve Class I posterior occlusion after treatment. 3. Good oral health free from caries and periodontal problems at the start of treatment. \-

Exclusion criteria

1. Previous history of orthopedic and/or orthodontic treatment. 2. Patients with cleft lip and palate and/or craniofacial syndrome 3. Patients with bad oral habit. 4. Active periodontal disease. 5. Sever rotation of maxillary molars. -

Design outcomes

Primary

MeasureTime frameDescription
The rate of molar Distalization6 months• The efficiency of molar distalization in terms of the amount of molar distalization, degree of distal tipping and bodily translation movements by using a lateral cephalogram linear and angular measurements.

Secondary

MeasureTime frameDescription
Patient discomfort10 days• Patient's pain and discomfort using visual analogue scale (VAS). The minimum score is zero and the maximum score is 10.
Molar distalization6 monthsThe efficiency of molar distalization in terms of the amount of molar distalization, degree of distal tipping and bodily translation movements by using a lateral cephalogram linear and angular measurements. - The efficiency of molar distalization in terms of the amount of molar distalization, - degree of distal tipping and bodily translation movements by using a lateral cephalogram linear and angular measurements

Countries

Iraq

Contacts

Primary ContactMushriq Abid Fawzi Professor, PhD
mushriq.abid@codental.uobaghdad.edu.iq009647718800706

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026